Matthew Fuchter is a Professor of Chemistry, co-Director of the Centre for Drug Discovery Science and co-Director of the MRes in Drug Discovery in the Department of Chemistry, Imperial College London. He was formally a member of the Organic Division Council of the Royal Society of Chemistry, and is currently the UK representative to the EuCheMS Division of Organic Chemistry and an Associate Editor of the RSC journal RSC Medicinal Chemistry (formally MedChemComm). He is involved in multiple multidisciplinary centres of excellence at Imperial including the Institute of Chemical Biology, the Imperial College Network of Excellence in Malaria, the Cancer Research Centre of Excellence, the Antimicrobial Research Collaborative, the Centre for Plastic Electronics and the London Centre for Nanotechnology.
See his research group website.
Professor Matthew Fuchter obtained his first class honours degree (MSci in Chemistry) from the University of Bristol in 2002, where he was awarded the Richard N. Dixon prize as well as an undergraduate Scholarship and several faculty commendations.
In January 2006 he completed his PhD research entitled “Synthetic Studies on Porphyrazines: Biological Applications and New Preparative Methods” under the supervision of Professor Anthony G. M. Barrett, FRS FMedSci (Imperial College London, UK) and in close collaboration with Professor Brian Hoffman (Northwestern University, USA). Following a short spell as a Research Associate at Imperial College, Professor Fuchter was appointed as a CSIRO Research Fellow at the Commonwealth Scientific and Industrial Research Organisation, Australia as well as a Visiting Fellow at the University of Melbourne, where he worked with Professor Andrew B Holmes, FRS.
He briefly took up an independent Fellowship position in 2007 at the School of Pharmacy (University of London), before being appointed as a Lecturer in Synthetic and Medicinal Chemistry at Imperial College London in July 2008. He was subsequently promoted to Senior Lecturer in July 2012, Reader in September 2015 and Professor in September 2018. In 2014 he was awarded the Royal Society of Chemistry's Harrison-Meldola Memorial Prize, as well as being admitted to the Royal Society of Chemistry as a Fellow. In 2015, he was selected as a Thieme Chemistry Journal Awardee by the Editorial Board for the Thieme Chemistry journals and received a Diploma for being the 'most meritorious runner-up' of the European Federation for Medicinal Chemistry (EFMC) Prize for a Young Medicinal Chemist in Academia (2015). In 2017, he won an Imperial College President’s Excellence in Research Award and a President’s Medal (together with Professors Tony Barrett, Charles Coombes and Simak Ali) for Excellence in Innovation and Entrepreneurship. In 2018 he was awarded the prestigious 2018 Tetrahedron Young Investigator Award for Bioorganic and Medicinal Chemistry and a 5-year EPSRC Established Career Fellowship. In 2020, he was an honouree for the 2020 Blavatnik Awards for Young Scientists in the United Kingdom, conferred by the Blavatnik Family Foundation and the New York Academy of Sciences.
et al., 2020, 500‐fold amplification of small molecule circularly polarized luminescence through circularly polarized FRET, Angewandte Chemie International Edition, ISSN:1433-7851
et al., 2020, TRPswitch — a step function chemo-optogenetic ligand for the vertebrate TRPA1 channel, Journal of the American Chemical Society, ISSN:0002-7863
et al., 2020, Highly efficient inverted circularly polarized organic light-emitting diodes, Acs Applied Materials & Interfaces, Vol:12, ISSN:1944-8244, Pages:39471-39478
et al., 2020, The transcriptional repressor REV-ERB as a novel target for disease, Bioorganic & Medicinal Chemistry Letters, Vol:30, ISSN:0960-894X, Pages:127395-127395
et al., 2020, Glycosylated nanoparticles derived from RAFT polymerization for effective drug delivery to macrophages, Acs Applied Bio Materials, Vol:3, ISSN:2576-6422, Pages:5775-5786